Krystal Biotech to Present at Association for Research in Vision and Ophthalmology Annual Meeting
April 13 2023 - 7:00AM
Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a
biotechnology company focused on developing and commercializing
genetic medicines for patients with rare diseases, announced today
that the Company will be presenting new data on the compassionate
use of topical beremagene geperpavec (B-VEC) to treat a patient
with dystrophic epidermolysis bullosa (DEB) with recurrent
cicatrizing conjunctivitis at the Association for Research in
Vision and Ophthalmology (ARVO) 2023 Annual Meeting being held
from April 23-27, 2023 in New Orleans, LA.
Presentation details are as follows:
Title: Topical beremagene
geperpavec (B-VEC) for the treatment of recurrent cicatrizing
conjunctivitis in a patient with dystrophic epidermolysis
bullosaPresenter: Alfonso L.
Sabater, M.D., PhD, University of Miami Health System Bascom Palmer
Eye Institute, Miami,
FLSession: Gene therapy and
gene editing for ocular disordersDate and
Time: April 23,
2023 from 12:00PM to 1:45PM CSTPresentation
Number: C0388
The poster will be available to conference attendees. Following
the presentation, materials will be available to view online on the
Investor section of the Company’s website.
About Krystal Biotech, Inc.Krystal Biotech,
Inc. (NASDAQ: KRYS) is a biotechnology company focused on
developing and commercializing genetic medicines for patients with
rare diseases. The Company’s wide-ranging pipeline is based on its
proprietary redosable HSV vector. Headquartered in Pittsburgh,
Pennsylvania, the Company is led by an experienced management team,
is fully-integrated and has core capabilities in viral vector
design, vector optimization, gene therapy manufacturing and
commercialization. For more information, please visit
http://www.krystalbio.com, and follow @KrystalBiotech on LinkedIn
and Twitter.
CONTACT
Investors and Media:
Meg Dodge
Krystal Biotech
mdodge@krystalbio.com
Krystal Biotech (NASDAQ:KRYS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Krystal Biotech (NASDAQ:KRYS)
Historical Stock Chart
From Jul 2023 to Jul 2024